【结 构 式】 |
【分子编号】16278 【品名】1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one 【CA登记号】2634-33-5 |
【 分 子 式 】C7H5NOS 【 分 子 量 】151.18884 【元素组成】C 55.61% H 3.33% N 9.26% O 10.58% S 21.21% |
合成路线1
该中间体在本合成路线中的序号:(IV)Reaction of the dicarboxylic acid (I) with thionyl chloride in hot toluene gives the di-acid chloride (II). Treatment of (II) with Cl2 in CH2Cl2 gives the sulfenyl chloride (III), which upon reaction with NH4OH affords the benzisothiazole (IV). Chlorination of (IV) in heat POCl3 yields the chlorobenzisothiazole (V). Reaction of (V) and piperazine (VI) in excess molten pipeazine gives the monosubstituted piperazine (VII). Reaction of (VII) with the dibromide (VIII) in refluxing ethanol yields the spiroquaternary (IX). Finally, BMY-13859-1 is obtained by treatment of (IX) with the glutarimide (X) in refluxing xylene followed by treatment with HCl in isopropanol.
【1】 Eison, M.S.; Taylor, D.P.; New, J.S.; Minielli, J.L.; BMY-13859. Drugs Fut 1985, 10, 9, 731. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10404 | Ethyl vanillin; 3-Ethoxy-4-hydroxybenzaldehyde | 121-32-4 | C9H10O3 | 详情 | 详情 |
(II) | 10405 | 2-Chloro-2-[3-ethoxy-4-(pentyloxy)phenyl]acetonitrile | C15H20ClNO2 | 详情 | 详情 | |
(III) | 28018 | 2-(chlorosulfanyl)benzoyl chloride | C7H4Cl2OS | 详情 | 详情 | |
(IV) | 16278 | 1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one | 2634-33-5 | C7H5NOS | 详情 | 详情 |
(V) | 16279 | 3-chloro-1,2-benzisothiazole | C7H4ClNS | 详情 | 详情 | |
(VI) | 10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 |
(VII) | 16280 | 3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl) | 87691-87-0 | C11H13N3S | 详情 | 详情 |
(VIII) | 11883 | 1,4-Dibromobutane; 1,4-Butylene bromide | 110-52-1 | C4H8Br2 | 详情 | 详情 |
(IX) | 28019 | 8-(1,2-benzisothiazol-3-yl)-8-aza-5-azoniaspiro[4.5]decane bromide | C15H20BrN3S | 详情 | 详情 | |
(X) | 28020 | 8-azaspiro[4.5]decane-7,9-dione | 1075-89-4 | C9H13NO2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)Wolff-Kishner reduction of 6-chloroisatin (I) gives 6-chlorooxindole (II), which is treated with chloroacetyl chloride under Friedel-Crafts conditions to yield 5-chloroacetyl-6-chlorooxindole (III). The ketone (III) is reduced using triethylsilane in trifluoroacetic acid to produce 6-chloro-5-(2-chloroethyl)oxindole (IV). 1,2-Benzisothiazolin-3-one (V) is converted to 3-chloro-1,2-benzisothiazole (VI) using phosphorus oxychloride and is then condensed with piperazine to provide 1-(1,2-benzisothiazol-3-yl)piperazine (VII). Finally, intermediate (VII) is alkylated by compound (IV) in the presence of sodium carbonate in water and is converted to the salt with aqueous hydrochloric acid.
【1】 Lowe, J.A. III; Nagel, A.A. (Pfizer Inc.); Piperazinyl-heterocyclic cpds. US 4831031 . |
【2】 Bowles, P. (Pfizer Inc.); Process for preparing aryl piperazinyl-heterocyclic cpds. EP 1029861; JP 1994184143; US 5206366 . |
【3】 Howard, H.R. Jr.; Busch, F.R.; Grobin, A.W.; Leeman, K.R. (Pfizer Products Inc.); Controlled synthesis of ziprasidone and compsns. thereof. WO 0370246 . |
【4】 Seeger, T.F.; Prakash, C.; Howard, H.R.; Ziprasidone Hydrochloride. Drugs Fut 1994, 19, 6, 560. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 | |
(I) | 16274 | 6-chloro-1H-indole-2,3-dione; 6-Chloroisatin | 6341-92-0 | C8H4ClNO2 | 详情 | 详情 |
(II) | 16275 | 6-chloro-1,3-dihydro-2H-indol-2-one | 56341-37-8 | C8H6ClNO | 详情 | 详情 |
(III) | 16276 | 6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one | C10H7Cl2NO2 | 详情 | 详情 | |
(IV) | 16277 | 6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one- | C10H9Cl2NO | 详情 | 详情 | |
(V) | 16278 | 1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one | 2634-33-5 | C7H5NOS | 详情 | 详情 |
(VI) | 16279 | 3-chloro-1,2-benzisothiazole | C7H4ClNS | 详情 | 详情 | |
(VII) | 16280 | 3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl) | 87691-87-0 | C11H13N3S | 详情 | 详情 |